Have a personal or library account? Click to login
Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach Cover

Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach

Acta Pharmaceutica
Volume 67 (2017): Issue 1 (March 2017)
By: Alexandru Gavan,  Alina Porfire,  Cristina Marina and  Ioan Tomuta  
Open Access
|Feb 2017

Authors

Alexandru Gavan

University of Medicine and Pharmacy „Iuliu Hatieganu” Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, Cluj-Napoca, Romania

Alina Porfire

aporfire@umfcluj.ro

University of Medicine and Pharmacy „Iuliu Hatieganu” Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, Cluj-Napoca, Romania

Cristina Marina

University of Medicine and Pharmacy „Iuliu Hatieganu” Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, Cluj-Napoca, Romania

Ioan Tomuta

University of Medicine and Pharmacy „Iuliu Hatieganu” Faculty of Pharmacy Department of Pharmaceutical Technology and Biopharmaceutics, Cluj-Napoca, Romania
DOI: https://doi.org/10.1515/acph-2017-0009 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 53 - 70
Accepted on: Dec 3, 2016
|
Published on: Feb 21, 2017
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
quality by design,
design of experiments,
sustained release,
hydrophilic matrix,
quetiapine
Related subjects:
Pharmacy,
Pharmacy, other

© 2017 Alexandru Gavan, Alina Porfire, Cristina Marina, Ioan Tomuta, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 67 (2017): Issue 1 (March 2017)Next article